By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today announced it has received approval from the US Food and Drug Administration to market the Abbott RealTime HBV assay for measuring the viral load of hepatitis B in patients.

The test is the first automated molecular test for assessing HBV viral load to receive FDA approval, Abbott said.

Other molecular HBV tests that aren't automated that have received FDA approval include Roche's Cobas TaqMan HBV Test and Gen-Probe's Procleix Ultrio assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.